The results indicated that El1405 modulated gut microbiota, reduced levels of inflammatory cytokines, and produced anti-inflammatory metabolites, such as IAA and ILA, thereby effectively alleviating DSS-induced colitis. Here, TNFRSF9 is linked to colitis.